ChronoRX LLC
Records under this name other than patents ChronoRX LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,060,295 | Formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus Lapsed on the fee record Ended Jun 13, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jun 13, 2014 | From the USPTO record |
| US 6,288,106 | Processes for the synthesis and use of various .alpha.-lipoic acid complexes Lapsed on the fee record Ended Sep 11, 2013 · From the USPTO record | Lapsed on the fee record | Ended Sep 11, 2013 | From the USPTO record |
| US 7,351,715 | Unit dosage forms for the treatment of herpes simplex Lapsed on the fee record Ended Apr 1, 2012 · From the USPTO record | Lapsed on the fee record | Ended Apr 1, 2012 | From the USPTO record |
| US 6,042,849 | Unit dosage forms for treatment of vasoconstriction and related conditions Lapsed on the fee record Ended Mar 28, 2012 · From the USPTO record | Lapsed on the fee record | Ended Mar 28, 2012 | From the USPTO record |
| US 6,693,094 | Biguanide and sulfonylurea formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus Lapsed on the fee record Ended Feb 17, 2012 · From the USPTO record | Lapsed on the fee record | Ended Feb 17, 2012 | From the USPTO record |
| US 6,689,385 | Formulations for the treatment of insulin resistance and type 2 diabetes mellitus Lapsed on the fee record Ended Feb 10, 2012 · From the USPTO record | Lapsed on the fee record | Ended Feb 10, 2012 | From the USPTO record |
| US 6,632,445 | Unit dosage forms for the treatment of herpes simplex Lapsed on the fee record Ended Oct 14, 2011 · From the USPTO record | Lapsed on the fee record | Ended Oct 14, 2011 | From the USPTO record |
| US 6,524,619 | Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus Lapsed on the fee record Ended Feb 25, 2011 · From the USPTO record | Lapsed on the fee record | Ended Feb 25, 2011 | From the USPTO record |
| US 6,455,061 | Unit dosage forms for the treatment of herpes simplex Lapsed on the fee record Ended Sep 24, 2010 · From the USPTO record | Lapsed on the fee record | Ended Sep 24, 2010 | From the USPTO record |
| US 6,429,219 | Treatment of chronic hypertension and related conditions with thiol complexes Lapsed on the fee record Ended Aug 6, 2010 · From the USPTO record | Lapsed on the fee record | Ended Aug 6, 2010 | From the USPTO record |